Is Microdosing Just Placebo?
People who microdose psychedelics claim that it provides a very wide range of benefits. Is it just a placebo effect?
Psychedelics & Drug Policy
-
Read more: Is Microdosing Just Placebo? -
Read more: What Macrodosing Can Learn from Microdosing What Macrodosing Can Learn from Microdosing
While standard doses of psychedelics will ostensibly be higher than a microdose, the question of just how much higher should be the topic of debate.
-
Read more: A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.
-
Read more: Setting a National Psychedelic Policy Agenda Setting a National Psychedelic Policy Agenda
RecordingEvent Description As the psychedelic renaissance unfolds, groups are forming to identify national policy priorities. This event assembled a panel of experts from several of these groups for a discussion on setting a national psychedelic policy agenda. Panelists Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
-
Read more: Reporting on the Psychedelic Legal Renaissance Reporting on the Psychedelic Legal Renaissance
RecordingEvent Description The psychedelic renaissance is characterized by growing interest in researching, commercializing, and consuming psychedelic substances like psilocybin and dimethyltryptamine (DMT). Against this backdrop, a wave of psychedelic legal reform is washing over North America. A dozen U.S. cities have decriminalized psychedelics, and about a dozen U.S. states have proposed laws to legalize these…
-
Read more: Psychedelics and Trauma Psychedelics and Trauma
RecordingEvent Description Psychedelic substances such as psilocybin, MDMA, and ketamine are being used increasingly in research and clinical settings. They also are being decriminalized and legalized by cities and states across the country. As research and access advance, a growing body of evidence suggests that one promising application for psychedelics is in the treatment of…
-
Read more: Coalition Building to Unlock the Therapeutic Effects of Psychedelics Coalition Building to Unlock the Therapeutic Effects of Psychedelics
Event Description The Solomon Center for Health Law and Policy welcomes you to join them for their first event of the year! This panel invited experts and change-makers from various backgrounds to discuss the therapeutic potential of psychedelics, and how to utilize collective action and coalition building to move access and innovation in the field…
-
Read more: Ethics in Psychedelic Therapy and Research Ethics in Psychedelic Therapy and Research
RecordingEvent Description Psychedelic substances like psilocybin, MDMA, and ketamine are increasingly used in research and clinical medicine. By their very nature, they put patients in a vulnerable position. The altered state of consciousness produced by psychedelics can promote insight and healing. However, unscrupulous practitioners can also exploit patients when they are under the influence of…
-
Read more: Introducing POPLAR: The Future of Psychedelics Law and Regulation Introducing POPLAR: The Future of Psychedelics Law and Regulation
RecordingEvent Description On June 30, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced a new research initiative, the Project on Psychedelics Law and Regulation (POPLAR). To mark POPLAR’s launch, the Petrie-Flom Center has invited experts from all aspects of the emerging psychedelics industry — including clinicians, researchers, patient…
-
Read more: Mental Health Moonshot: Unlocking Federal Funds for Psychedelics Research Mental Health Moonshot: Unlocking Federal Funds for Psychedelics Research
RecordingEvent Description The U.S. needs a mental health moonshot. Inspired by the Apollo moon landing, moonshots are ambitious projects with monumental goals. The U.S. has a history of funding moonshots with federal tax dollars, and the Human Genome Project is one recent example. More recently, in 2016, President Obama and Vice President Biden announced the…
